Phone calls to follow up with patients with locally advanced esophageal squamous cell carcinoma while at home may reduce AEs ...

ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer ...

ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer ...

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...

Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...

Findings from this survey also demonstrated that 23% of providers were comfortable with interpreting biomarker testing ...

Treosulfan plus fludarabine was approved by the FDA for children and adults with AML or MDS before allogenic hematopoietic ...

The phase 3 RATIONALE-306 study found no significant difference in overall survival benefits from tislelizumab plus ...

22% of Community Providers Reported Biomarker Testing in Gastric/GEJ Cancers ...